KAS
IDNA icon

Kestra Advisory Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Kestra Advisory Services’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,963
Closed -$77.6K – 3714
2025
Q4 		$77.6K Buy
+2,963
New +$76.2K ﹤0.01% 3623
2024
Q4 		– Sell
-8,871
Closed -$218K – 2735
2024
Q3 		$218K Sell
8,871
-3,320
-27% -$80.9K ﹤0.01% 2318
2024
Q2 		$282K Sell
12,191
-1,402
-10% -$32.8K ﹤0.01% 2151
2024
Q1 		$327K Hold
13,593
– – ﹤0.01% 1940
2023
Q4 		$313K Sell
13,593
-1,024
-7% -$20.6K ﹤0.01% 1820
2023
Q3 		$297K Buy
14,617
+5,426
+59% +$122K ﹤0.01% 1660
2023
Q2 		$215K Sell
9,191
-12,354
-57% -$296K ﹤0.01% 1863
2023
Q1 		$501K Sell
21,545
-13,878
-39% -$347K 0.01% 1277
2022
Q4 		$892K Sell
35,423
-17,046
-32% -$458K 0.01% 1108
2022
Q3 		$1.39M Buy
52,469
+1,448
+3% +$44.7K 0.01% 820
2022
Q2 		$1.48M Sell
51,021
-6,626
-11% -$198K 0.02% 790
2022
Q1 		$1.99M Buy
57,647
+8,757
+18% +$309K 0.02% 681
2021
Q4 		$2.14M Buy
48,890
+22,968
+89% +$1.09M 0.02% 653
2021
Q3 		$1.31M Buy
25,922
+7,584
+41% +$395K 0.01% 877
2021
Q2 		$954K Buy
18,338
+3,194
+21% +$150K 0.01% 970
2021
Q1 		$692K Buy
15,144
+3,617
+31% +$177K 0.01% 1036
2020
Q4 		$541K Buy
+11,527
New +$498K 0.01% 1168

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Kestra Advisory Services's IDNA Position: Q1 2026 in Review

Kestra Advisory Services sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2026, closing a stake of 2,963 shares — an estimated $77.6K sold.

Kestra Advisory Services first reported a position in IDNA in Q4 2020 and held it in 17 quarters. The position peaked at $2.14M in Q4 2021. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Kestra Advisory Services reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 2,963 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $77.6K.
  • Kestra Advisory Services first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2020 and held it in 17 quarters.
  • Kestra Advisory Services's iShares Genomics Immunology and Healthcare ETF position peaked at $2.14M in Q4 2021.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.